-
Je něco špatně v tomto záznamu ?
Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors
M. Pekarová, J. Králová, L. Kubala, M. Číž, I. Papežíková, T. Mačičková, J. Pečivová, R. Nosáľ, A. Lojek
Jazyk angličtina Země Polsko
Typ dokumentu práce podpořená grantem
PubMed
19439816
Knihovny.cz E-zdroje
- MeSH
- adrenergní receptory metabolismus účinky léků MeSH
- agonisté adrenergních receptorů farmakologie MeSH
- alfa blokátory farmakologie MeSH
- beta blokátory aplikace a dávkování farmakologie MeSH
- buněčné linie MeSH
- dusitany metabolismus MeSH
- karbazoly aplikace a dávkování farmakologie MeSH
- lipopolysacharidy MeSH
- makrofágy metabolismus účinky léků MeSH
- myši MeSH
- oxid dusnatý metabolismus MeSH
- propanolaminy aplikace a dávkování farmakologie MeSH
- regulace genové exprese enzymů účinky léků MeSH
- signální transdukce účinky léků MeSH
- synthasa oxidu dusnatého, typ II metabolismus účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
The interaction of adrenergic agonists and/or antagonists with the adrenergic receptors expressed on immunologically active cells including macrophages plays an important role in regulation of inflammatory responses. Our study investigated the effects of carvedilol, a unique vasodilating beta-adrenergic antagonist, and endogenous adrenergic agonists (adrenalin, noradrenalin, and dopamine) and/or antagonists (prazosin, atenolol) on lipopolysaccharide-stimulated nitric oxide (NO) production from murine macrophage cell line RAW 264.7. The production of NO was determined as the concentration of nitrites in cell supernatants (Griess reaction) and inducible nitric oxide synthase (iNOS) protein expression (Western blot analysis). Scavenging properties against NO were measured electrochemically. Carvedilol in a concentration range of 1, 5, 10 and 25 microM inhibited iNOS protein expression and decreased the nitrite concentration in cell supernatants. Adrenalin, noradrenalin or dopamine also inhibited the iNOS protein expression and the nitrite accumulation. Prazosine and atenolol prevented the effect of both carvedilol and adrenergic agonists on nitrite accumulation and iNOS expression in lipopolysaccharide-stimulated cells. These results, together with the absence of scavenging properties of carvedilol against NO, imply that both carvedilol and adrenergic agonists suppress the lipopolysaccharide-evoked NO production by macrophages through the activation and modulation of signaling pathways connected with adrenergic receptors.
- 000
- 03922naa 2200577 a 4500
- 001
- bmc11017154
- 003
- CZ-PrNML
- 005
- 20121203110047.0
- 008
- 110629s2009 pl e eng||
- 009
- AR
- 035 __
- $a (PubMed)19439816
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Pekarová, Michaela, $d 1982-2019 $7 mub2011659519
- 245 10
- $a Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors / $c M. Pekarová, J. Králová, L. Kubala, M. Číž, I. Papežíková, T. Mačičková, J. Pečivová, R. Nosáľ, A. Lojek
- 314 __
- $a Institute of Biophysics of the AS CR, Kralovopolska, Kralovopolska 135, Brno, Czech Republic.
- 520 9_
- $a The interaction of adrenergic agonists and/or antagonists with the adrenergic receptors expressed on immunologically active cells including macrophages plays an important role in regulation of inflammatory responses. Our study investigated the effects of carvedilol, a unique vasodilating beta-adrenergic antagonist, and endogenous adrenergic agonists (adrenalin, noradrenalin, and dopamine) and/or antagonists (prazosin, atenolol) on lipopolysaccharide-stimulated nitric oxide (NO) production from murine macrophage cell line RAW 264.7. The production of NO was determined as the concentration of nitrites in cell supernatants (Griess reaction) and inducible nitric oxide synthase (iNOS) protein expression (Western blot analysis). Scavenging properties against NO were measured electrochemically. Carvedilol in a concentration range of 1, 5, 10 and 25 microM inhibited iNOS protein expression and decreased the nitrite concentration in cell supernatants. Adrenalin, noradrenalin or dopamine also inhibited the iNOS protein expression and the nitrite accumulation. Prazosine and atenolol prevented the effect of both carvedilol and adrenergic agonists on nitrite accumulation and iNOS expression in lipopolysaccharide-stimulated cells. These results, together with the absence of scavenging properties of carvedilol against NO, imply that both carvedilol and adrenergic agonists suppress the lipopolysaccharide-evoked NO production by macrophages through the activation and modulation of signaling pathways connected with adrenergic receptors.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a agonisté adrenergních receptorů $x farmakologie $7 D000322
- 650 _2
- $a alfa blokátory $x farmakologie $7 D000317
- 650 _2
- $a beta blokátory $x aplikace a dávkování $x farmakologie $7 D000319
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a karbazoly $x aplikace a dávkování $x farmakologie $7 D002227
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a regulace genové exprese enzymů $x účinky léků $7 D015971
- 650 _2
- $a lipopolysacharidy $7 D008070
- 650 _2
- $a makrofágy $x metabolismus $x účinky léků $7 D008264
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a synthasa oxidu dusnatého, typ II $x metabolismus $x účinky léků $7 D052247
- 650 _2
- $a dusitany $x metabolismus $7 D009573
- 650 _2
- $a propanolaminy $x aplikace a dávkování $7 D011412
- 650 _2
- $a propanolaminy $x farmakologie $7 D011412
- 650 _2
- $a adrenergní receptory $x metabolismus $x účinky léků $7 D011941
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1#
- $a Králová, Jana. $7 _AN059470
- 700 1_
- $a Kubala, Lukáš, $d 1973- $7 xx0094314
- 700 1_
- $a Číž, Milan. $7 jx20080610039
- 700 1_
- $a Papežíková, Ivana $7 xx0098961
- 700 1_
- $a Mačičková, Tatiana $7 xx0060743
- 700 1_
- $a Pečivová, Jana $7 xx0112233
- 700 1_
- $a Nosáľ, Radomír, $d 1941- $7 mzk2003196550
- 700 1_
- $a Lojek, Antonín, $d 1954- $7 xx0063943
- 773 0_
- $t Journal of Physiology & Pharmacology $g Roč. 60, č. 1 (2009), s. 143-150 $w MED00002908
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110720102337 $b ABA008
- 991 __
- $a 20121203110118 $b ABA008
- 999 __
- $a ok $b bmc $g 864183 $s 726951
- BAS __
- $a 3
- BMC __
- $a 2009 $b 60 $c 1 $d 143-150 $m Journal of physiology and pharmacology $n J Physiol Pharmacol $x MED00002908
- LZP __
- $a 2011-3B09/BBjvme